Cargando…
Management of Recurrent Retroperitoneal Sarcoma
Recurrence after resection of retroperitoneal sarcoma is common and varies by histological subtype. Pattern of recurrence is similarly affected by histology (e.g., well-differentiated liposarcoma is more likely to recur locoregionally, whereas leiomyosarcoma is more likely to develop distant metasta...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047230/ https://www.ncbi.nlm.nih.gov/pubmed/36975422 http://dx.doi.org/10.3390/curroncol30030209 |
_version_ | 1785013868713476096 |
---|---|
author | Jolissaint, Joshua S. Raut, Chandrajit P. Fairweather, Mark |
author_facet | Jolissaint, Joshua S. Raut, Chandrajit P. Fairweather, Mark |
author_sort | Jolissaint, Joshua S. |
collection | PubMed |
description | Recurrence after resection of retroperitoneal sarcoma is common and varies by histological subtype. Pattern of recurrence is similarly affected by histology (e.g., well-differentiated liposarcoma is more likely to recur locoregionally, whereas leiomyosarcoma is more likely to develop distant metastases). Radiotherapy may provide effective locoregional control in limited circumstances and the data on the impact of chemotherapy are scant. Surgery for locally recurrent disease is associated with the greatest survival benefit; however, data are retrospective and from a highly selected subgroup of patients. Limited retrospective data have also suggested a survival association with the resection of limited distant metastases. Given the complexity of these patients, multidisciplinary evaluation at a high-volume sarcoma center is critical. |
format | Online Article Text |
id | pubmed-10047230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100472302023-03-29 Management of Recurrent Retroperitoneal Sarcoma Jolissaint, Joshua S. Raut, Chandrajit P. Fairweather, Mark Curr Oncol Review Recurrence after resection of retroperitoneal sarcoma is common and varies by histological subtype. Pattern of recurrence is similarly affected by histology (e.g., well-differentiated liposarcoma is more likely to recur locoregionally, whereas leiomyosarcoma is more likely to develop distant metastases). Radiotherapy may provide effective locoregional control in limited circumstances and the data on the impact of chemotherapy are scant. Surgery for locally recurrent disease is associated with the greatest survival benefit; however, data are retrospective and from a highly selected subgroup of patients. Limited retrospective data have also suggested a survival association with the resection of limited distant metastases. Given the complexity of these patients, multidisciplinary evaluation at a high-volume sarcoma center is critical. MDPI 2023-02-25 /pmc/articles/PMC10047230/ /pubmed/36975422 http://dx.doi.org/10.3390/curroncol30030209 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Jolissaint, Joshua S. Raut, Chandrajit P. Fairweather, Mark Management of Recurrent Retroperitoneal Sarcoma |
title | Management of Recurrent Retroperitoneal Sarcoma |
title_full | Management of Recurrent Retroperitoneal Sarcoma |
title_fullStr | Management of Recurrent Retroperitoneal Sarcoma |
title_full_unstemmed | Management of Recurrent Retroperitoneal Sarcoma |
title_short | Management of Recurrent Retroperitoneal Sarcoma |
title_sort | management of recurrent retroperitoneal sarcoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047230/ https://www.ncbi.nlm.nih.gov/pubmed/36975422 http://dx.doi.org/10.3390/curroncol30030209 |
work_keys_str_mv | AT jolissaintjoshuas managementofrecurrentretroperitonealsarcoma AT rautchandrajitp managementofrecurrentretroperitonealsarcoma AT fairweathermark managementofrecurrentretroperitonealsarcoma |